Inherited retinal diseases: advances in imaging to accelerate progress in therapy

Recent advances in genetics and molecular biology have fostered the development of several treatments for IRDs, with the...

Euretina 2021 – Progression rate of retinitis pigmentosa measured over 6 months

Researchers at the Lions Eye Institute present a longitudinal study that assessed the progression of RP with both OCT and rtx1...

Euretina 2021 – Retinal imaging beyond photoreceptor cells

Users of Imagine Eyes’ rtx1 adaptive optics retinal cameras  will report a number of new and extraordinary explorations...

Short-term assessment of photoreceptor rescue after gene therapy

Leber congenital amaurosis (LCA) has been the first inherited retinal disease with a gene therapy approved for clinical use.…

Review article: microvascular biomarkers assessed with adaptive optics

Adaptive optics (AO) imaging has brought unique possibilities for assessing retinal blood vessels, thanks to direct visualizations…

rtx1 users’ e-symposium 2021

Last week, Imagine Eyes held the first edition of the rtx1 users' e-symposium. Clinicians, researchers and ophthalmic photographers…

Clinical and animal findings with adaptive optics retinal cameras

In recent years, not only clinical investigators, but also animal researchers have increasingly adopted the rtx1 AO camera…

New video on adaptive optics retinal imaging

In a brief format, a new video shows how clinicians use the rtx1 Adaptive Optics Retinal Camera to reveal microscopic lesions…

ARVO 2021: Phenotyping at the cellular level in the retina

This year at ARVO 2021, users of Imagine Eyes’ rtx1 report clinical and animal findings in several diseases. They present new phenotype information at the cellular level in the retina, obtained with adaptive optics imaging.

Novel clinical findings with rtx1 got published

Published last month, 4 Adaptive Optics studies report novel findings in retinal diseases, diabetes, and in subjects with…